Dataset from A Phase 4, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Mirabegron in Japanese and Korean Male Patients With Overactive Bladder Under Treatment With the α-Blocker Tamsulosin for Benign Prostatic Hyperplasia

NIAID Data Ecosystem2026-05-02 收录

泌尿药物临床试验

良性前列腺增生合并膀胱过度活动症

数据链接：

https://doi.org/10.25934/PR00010658 数据链接链接失效反馈

官方服务：

资源简介：

The primary objective of the study was to investigate the efficacy of mirabegron versus placebo in male patients with OAB symptoms while taking the alpha blocker, tamsulosin, for BPH.

创建时间：

2025-02-10

Dataset from A Phase 4, Double-blind, Randomized, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Mirabegron in Japanese and Korean Male Patients With Overactive Bladder Under Treatment With the α-Blocker Tamsulosin for Benign Prostatic Hyperplasia

资源简介：

相关数据集